Cargando…
LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats
BACKGROUND: Lung transplantation is the only effective treatment for end-stage lung diseases. Bronchiolitis obliterans, which is known as non-infectious chronic lung allograft dysfunction (CLAD) in the new classification, is the greatest threat to long-term survival after lung transplantation. This...
Autores principales: | Tu, Zheng-Liang, Zhou, Zhen-Yu, Xu, Hai-Chao, Cao, Jin-Lin, Ye, Peng, Wang, Lu-Ming, Lv, Wang, Hu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445521/ https://www.ncbi.nlm.nih.gov/pubmed/28545478 http://dx.doi.org/10.1186/s13019-017-0605-5 |
Ejemplares similares
-
Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial
por: Ruttens, David, et al.
Publicado: (2018) -
Therapeutic effect of budesonide, montelukast and azithromycin on post-infectious bronchiolitis obliterans in children
por: Chen, Xia, et al.
Publicado: (2020) -
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
por: Kim, Sei Won, et al.
Publicado: (2016) -
The role of epithelial-mesenchymal transition in the post-lung transplantation bronchiolitis obliterans
por: Zhang, Chong, et al.
Publicado: (2017) -
Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
por: Vanstapel, Arno, et al.
Publicado: (2021)